X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE ALEMBIC LTD TTK HEALTHCARE/
ALEMBIC LTD
 
P/E (TTM) x 18.0 49.9 36.1% View Chart
P/BV x 4.6 2.0 227.7% View Chart
Dividend Yield % 0.6 0.5 125.1%  

Financials

 TTK HEALTHCARE   ALEMBIC LTD
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
ALEMBIC LTD
Mar-18
TTK HEALTHCARE/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs66372 921.4%   
Low Rs39934 1,177.0%   
Sales per share (Unadj.) Rs535.64.7 11,394.8%  
Earnings per share (Unadj.) Rs15.96.1 261.3%  
Cash flow per share (Unadj.) Rs20.06.2 320.7%  
Dividends per share (Unadj.) Rs4.000.20 2,000.0%  
Dividend yield (eoy) %0.80.4 199.4%  
Book value per share (Unadj.) Rs137.640.7 338.5%  
Shares outstanding (eoy) m7.77267.03 2.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.011.3 8.8%   
Avg P/E ratio x33.38.7 384.0%  
P/CF ratio (eoy) x26.58.5 312.9%  
Price / Book Value ratio x3.91.3 296.4%  
Dividend payout %25.13.3 765.5%   
Avg Mkt Cap Rs m4,12714,139 29.2%   
No. of employees `0001.7NA-   
Total wages/salary Rs m607207 292.5%   
Avg. sales/employee Rs Th2,436.7NM-  
Avg. wages/employee Rs Th355.2NM-  
Avg. net profit/employee Rs Th72.5NM-  
INCOME DATA
Net Sales Rs m4,1621,255 331.6%  
Other income Rs m61370 16.5%   
Total revenues Rs m4,2231,625 259.8%   
Gross profit Rs m197111 177.4%  
Depreciation Rs m3238 83.9%   
Interest Rs m302 1,758.8%   
Profit before tax Rs m197442 44.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7324 304.0%   
Profit after tax Rs m1241,630 7.6%  
Gross profit margin %4.78.9 53.5%  
Effective tax rate %37.05.4 682.7%   
Net profit margin %3.0129.8 2.3%  
BALANCE SHEET DATA
Current assets Rs m1,6291,867 87.2%   
Current liabilities Rs m1,058591 178.9%   
Net working cap to sales %13.7101.6 13.5%  
Current ratio x1.53.2 48.8%  
Inventory Days Days3094 31.6%  
Debtors Days Days3474 45.7%  
Net fixed assets Rs m5561,791 31.1%   
Share capital Rs m78534 14.5%   
"Free" reserves Rs m87810,324 8.5%   
Net worth Rs m1,06910,858 9.8%   
Long term debt Rs m15941 385.2%   
Total assets Rs m2,39911,591 20.7%  
Interest coverage x7.6260.9 2.9%   
Debt to equity ratio x0.10 3,911.3%  
Sales to assets ratio x1.70.1 1,601.7%   
Return on assets %6.414.1 45.5%  
Return on equity %11.615.0 77.2%  
Return on capital %18.515.2 121.5%  
Exports to sales %0.81.5 51.1%   
Imports to sales %1.421.0 6.7%   
Exports (fob) Rs m3319 169.6%   
Imports (cif) Rs m58263 22.1%   
Fx inflow Rs m3319 169.6%   
Fx outflow Rs m63264 24.0%   
Net fx Rs m-30-244 12.4%   
CASH FLOW
From Operations Rs m127236 53.7%  
From Investments Rs m-146-224 65.2%  
From Financial Activity Rs m22-27 -82.3%  
Net Cashflow Rs m3-15 -16.9%  

Share Holding

Indian Promoters % 65.4 64.0 102.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 0.2 1,850.0%  
FIIs % 5.2 9.7 53.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 26.1 98.9%  
Shareholders   12,723 54,701 23.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Where Will the Two-Faced Market Go from Here?(Podcast)

The stock markets are very volatile these days. As the Tanushree Bannerjee, the co-head of research here at Equitymaster puts it, stock markets are two-faced.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

Feb 4, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

Here's What the Biggest 'Rebirth of India' Investors are Doing(The 5 Minute Wrapup)

Feb 5, 2019

A roundtable on the 18th of January 2019 had investors with billions of dollars of investment kitty.

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Do You Have the Stomach to Survive a Small Cap Crash?(Profit Hunter)

Feb 5, 2019

While selecting good businesses is relatively easy task in a bearish phase, where most people fail is in having enough patience to hold the quality stocks until recovery.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 15, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - FDC LTD. COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS